The great ulcer war
Subtitle: how an axis of an American university research group and a global pharmaceutical company attacked one of the great medical discoveries of the twentieth century
By: William S. Hughes
Publisher: William S. Hughes
Published: 2014
Place of publication: Washington, DC
Language: eng
Number of pages: 293
ISBN-13: 9781941142172
Subjects: Helicobacter pylori; Helicobacter pylori infections; Peptic ulcer; Etiology; Pathogenicity; Peptic Ulcer; Drug therapy; Dissent and Disputes; Drug Industry; Biomedical Research
Description: "In 1983, in Australia, a medical resident, Dr. Barry Marshall, and a hospital pathologist, Dr. Robin Warren, reported in two letters to The Lancet finding a bacterium associated with gastritis or inflammation of the stomach. The publication stimulated little reaction. However, a year later when they reported that the bacterium was also associated with ulcer disease and declared that bacteria caused ulcer disease, it had the effect of an assassination of an archduke. Most prominent clinical investigators in the United States and England argued that hyper secretion of acid was the cause of ulcer disease, and they collaborated with the pharmaceutical companies that made the new drugs that blocked acid secretion to attack the new bacterial theory. The Great Ulcer War tells how the war was fought, the weapons used, and the alliances made, and why the war in spite of overwhelming evidence in favor of the bacterial theory, lasted for ten years. The Great Ulcer War introduces a novel theory, the Pandora Hypothesis, to explain the length of the war. It proposes that the general medical establishment especially in the United States simply did not like the bacterial theories of major chronic diseases. These thought leaders -- "the big guys"--Facilitated and prolonged the opposition to the bacterial theory of ulcers largely by doing nothing to support the theory until the very end of the war. They were afraid that if a germ theory was accepted for ulcers, a Pandora's Box of germ theories developed within university departments of microbiology for other chronic diseases would be opened and released into the medical world. This revelation would diminish the reputation and profit of the medical establishment and the pharmaceutical industry by threatening their favored explanations of the causes of these diseases: genomic errors and dysfunctional biochemistry and physiology."--Publisher.
Notes: Includes bibliographical references and index.